Invesco Ltd. Evelo Biosciences, Inc. Transaction History

Invesco Ltd.

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.46 - $3.55 $16,854 - $40,981	-11,544 Closed	0 $0
Q1 2022 May 16, 2022	BUY	$2.66 - $6.63 $444 - $1,107	167 Added 1.47%	11,544 $39,000
Q4 2021 Feb 14, 2022	BUY	$6.07 - $12.0 $3,035 - $6,000	500 Added 4.6%	11,377 $69,000
Q3 2021 Nov 15, 2021	BUY	$6.79 - $13.9 $73,854 - $151,190	10,877 New	10,877 $77,000
Q2 2021 Aug 17, 2021	SELL	$9.43 - $16.6 $1.55 Million - $2.73 Million	-164,459 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$9.71 - $18.6 $267,762 - $512,913	27,576 Added 20.15%	164,459 $1.76 Million
Q4 2020 Feb 16, 2021	BUY	$3.91 - $12.28 $535,212 - $1.68 Million	136,883 New	136,883 $1.65 Million

Ticker EVLO
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 107,994,000
Description
Evelo Biosciences, Inc., a biotechnology company, discovers and develops oral biologics for the treatment of inflammatory diseases and cancer. It is developing EDP1815, a whole-microbe candidate for the treatment of inflammatory diseases; and is in Phase 2 clinical trial for the treatment of psoriasis and atopic dermatitis, as well as for the hy...

Get notified when there are updates to the investment portfolio of Invesco Ltd., based on Form 13F filings with the SEC.

Stay updated on Invesco Ltd. with notifications on news.